We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$439M
AUM Growth
+$23.9M
Cap. Flow
-$10.8M
Cap. Flow %
-2.47%
Top 10 Hldgs %
31.85%
Holding
402
New
25
Increased
73
Reduced
73
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 24.85%
2 Miscellaneous 14.07%
3 Healthcare 14%
4 Financials 13.95%
5 Consumer Staples 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCRX icon
326
Pacira BioSciences
PCRX
$1.03B
$6K ﹤0.01%
104
VTRS icon
327
Viatris
VTRS
$18.8B
$6K ﹤0.01%
405
-103
-20% -$1.49K
CFMS
328
DELISTED
Conformis, Inc. Common Stock
CFMS
$6K ﹤0.01%
200
DAL icon
329
Delta Air Lines
DAL
$52.7B
$5K ﹤0.01%
120
EMBJ
330
Embraer S.A. ADS
EMBJ
$12.9B
$5K ﹤0.01%
360
GSG icon
331
iShares S&P GSCI Commodity-Indexed Trust
GSG
$967M
$5K ﹤0.01%
300
JETS icon
332
US Global Jets ETF
JETS
$783M
$5K ﹤0.01%
+200
New +$5.22K
JMIA
333
Jumia Technologies
JMIA
$865M
$5K ﹤0.01%
150
MFC icon
334
Manulife Financial
MFC
$70.9B
$5K ﹤0.01%
268
MUSA icon
335
Murphy USA
MUSA
$9.25B
$5K ﹤0.01%
35
SSYS icon
336
Stratasys
SSYS
$678M
$5K ﹤0.01%
200
FCEL icon
337
FuelCell Energy
FCEL
$1.42B
$4K ﹤0.01%
17
HSBC icon
338
HSBC
HSBC
$355B
$4K ﹤0.01%
150
PHO icon
339
Invesco Water Resources ETF
PHO
$2.05B
$4K ﹤0.01%
70
OPNT
340
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$4K ﹤0.01%
300
C icon
341
Citigroup
C
$223B
$3K ﹤0.01%
40
-75
-65% -$5.55K
GDX icon
342
VanEck Gold Miners ETF
GDX
$31B
$3K ﹤0.01%
100
DFTX
343
Definium Therapeutics
DFTX
$5.51B
$3K ﹤0.01%
+67
New +$3.52K
PIO icon
344
Invesco Global Water ETF
PIO
$274M
$3K ﹤0.01%
70
THCX
345
DELISTED
AXS Cannabis ETF
THCX
$3K ﹤0.01%
16
ACAD icon
346
Acadia Pharmaceuticals
ACAD
$5.02B
$2K ﹤0.01%
100
CI icon
347
Cigna
CI
$73.7B
$2K ﹤0.01%
8
GH icon
348
Guardant Health
GH
$21.7B
$2K ﹤0.01%
+20
New +$2.69K
LUMN icon
349
Lumen
LUMN
$6.23B
$2K ﹤0.01%
142
OXY icon
350
Occidental Petroleum
OXY
$59.1B
$2K ﹤0.01%
75

Similar funds

American Research & Management Company's Q2 2021 Portfolio in Review

As of Q2 2021, American Research & Management Company held 402 positions worth $439M, up 5.8% from $415M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

American Research & Management Company's Q2 2021 filing shows 25 new, 73 increased, 73 reduced and 15 closed positions. Its largest new stake was Ansys: 625 shares worth $217K. The largest sale was Texas Capital Bancshares, Inc. Non Cumulative Preferred Perpetual Stock Series A, an estimated $1.38M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Miscellaneous and Healthcare.

  • American Research & Management Company's largest Q2 2021 buy was Ansys: 625 shares worth $217K.
  • American Research & Management Company added most to Vanguard Morningstar Small-Cap Value ETF in Q2 2021, an estimated $1.04M increase.
  • American Research & Management Company's biggest Q2 2021 reduction was Texas Capital Bancshares, Inc. Non Cumulative Preferred Perpetual Stock Series A, cutting an estimated $1.38M.
  • American Research & Management Company fully exited Fidelity Corporate Bond ETF in Q2 2021, selling an estimated $27K.
  • American Research & Management Company's ten largest holdings make up 32% of its $439M portfolio in Q2 2021.
  • American Research & Management Company opened 25 new positions and closed 15 in Q2 2021.
  • American Research & Management Company's portfolio value rose 5.8% quarter-over-quarter to $439M.

Based on American Research & Management Company's 13F filing for Q2 2021, filed 16 Jul 2021.